Search
for
Sort by
Research 871–900 of 895
- Hair Disorders in Autoimmune Diseases
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
- A systematic review on Drug Re-profiling/Re-Purposing
- The spectrum of fibrosing alopecias
- Conference 2022, The Sequel
- SnapshotDx Quiz: April 2022
- Ischemic Vaso-occlusive Retinopathy as Initial Presentation in Pediatric Systemic Lupus Erythematosus: A Case Report
- SnapshotDx Quiz: January 2021
- Frontal fibrosing alopecia: state of the art and future directions
- Atypical Presentation of Lichen Planopilaris: Presentation of Two Cases and Review
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Proceedings of the Ninth World Congress for Hair Research (2015)
- Fever of unknown origin in a male patient with systemic lupus erythematosus.
- Frontal Fibrosing Alopecia
- Undifferentiated connective tissue disease presenting with vascular pattern of renal amyloidosis with carpel tunnel syndrome: A case report
- Oral Presentations
- Symptoms: Pruritic Skin Lesions
- Treatment of Frontal Fibrosing Alopecia
- Hair cell toxicology: With the help of a little fish
- Die Menopause und ihre Auswirkungen auf Haut und Haare
- Ayurvedic Rasayan formulations having potential for managing post COVID ailments- a narrative review
- Progression of Pseudolymphoma to true Cutaneous lymphoma, possible role of Platelet-rich plasma (PRP), a case report.
- Frontal fibrosing alopecia
- Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- Cutaneous lupus erythematosus
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Subacute cutaneous lupus erythematosus presenting as erythroderma
- Treatment of Generalized Lichen Planus With Alefacept
- Efficacy Observation on Mild to Moderate Active Systemic Lupus Erythematosus Treated with Compound Zishenqing Formula